We next analyzed the expression of IL1β, as well as of a number of inflammatory cytokines (IL6, TNFα), chemokine receptors (CXC3CR1, CCR5), and MAP kinases (MAPK1, MAP2K1, MAPK9) in resting PBMCs from a subgroup of 36 patients (27 patients with CAD and 9 controls). This evidence concerns the gene MAPK9 and coronary artery disorder.